Heparanase upregulation from adipocyte associates with inflammation and endothelial injury in diabetic condition

Nur Arfian; Wiwit Ananda Wahyu Setyaningsih; Muhammad Mansyur Romi; Dwi Cahyani Ratna Sari

doi:10.1186/s12919-019-0181-x

Heparanase upregulation from adipocyte associates with inflammation and endothelial injury in diabetic condition

BMC Proc. 2019 Dec 16;13(Suppl 11):17. doi: 10.1186/s12919-019-0181-x. eCollection 2019.

Authors

Nur Arfian¹, Wiwit Ananda Wahyu Setyaningsih¹, Muhammad Mansyur Romi¹, Dwi Cahyani Ratna Sari¹

Affiliation

¹ Department of Anatomy, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Abstract

Background: Diabetes Mellitus (DM) is one of the metabolic diseases which leads to fatty tissue injury, and consequently inducing lipotoxicity and cellular senescence. This condition contributes to endothelial dysfunction with chronic inflammation and organ damage. Heparanase which has a role in disrupting endothelial surface layer (glycocalyx) may promote endothelial Nitric oxide synthase (eNOS) reduction and inflammation. However, its relationship with DM and organ injury has not been fully elucidated yet. This study aimed to determine how heparanase from fatty tissue may contribute to endothelial dysfunction and inflammation in patients with hyperglycemia and in a hyperglycemia model in rats.

Methods: This population study with a cross-sectional design was conducted with 28 subjects without diagnosis and medication of DM. Fasting blood glucose levels, lipid profile, heparanase protein, MCP-1 protein and HbA1c were quantified. In vivo study was performed with a diabetic model in Wistar rats induced with streptozotocin 60 mg/kg body weight by single intraperitoneal injection. Rats were euthanized after 1 month (DM1 group, n = 6), 2 months (DM2 group, n = 6) and 4 months (DM4 group, n = 6). White Adipose Tissue (WAT) was harvested from visceral fat. Real Time and Reverse Transcriptase-PCR (RT-PCR) was done to quantify expressions of heparanase, MCP-1, eNOS, IL-6 and p-16 (senescence). Immunostaining was performed to localize MCP-1 and macrophage (CD68). Western blot tests were used to examine eNOS, MCP-1 and heparanase protein expression.

Results: This study revealed associations between blood glucose levels with higher HbA1c, LDL, cholesterol, heparanase and MCP-1. The in vivo study also revealed lipid levels as the source of Heparanase and MCP-1 mRNA and protein expressions. This finding was associated with inflammation, cellular senescence and macrophage infiltration in fat tissue based on immunostaining and qRT-PCR analysis. RT-PCR revealed significantly lower expression of eNOS and higher expression of IL-6 in DM groups compared to the control group.

Conclusion: Heparanase upregulation in fat tissue was associated with endothelial injury and inflammation in hyperglycemia conditions.

Keywords: Diabetes mellitus; Endothelial injury; Heparanase; Inflammation; MCP-1.